Hyperhomocysteinemia is usually associated with cardiovascular and renal disorders.
INTRODUCTION
Homocysteine is a homologue of the amino acid cysteine. It can be converted into cysteine or recycled into methionine with the aid of certain Bvitamins(1).
Hyperhomocysteinemia is an independent risk factor for cardiovascular diseases such as arteriosclerosis, coronary arteries and cerebrovascular disorders (2,3,4,5).
Hyperhomocystienemia is a risk factor for vascular Canal University in spacious plastic cages at controlled room temperature and were kept with free access to standard rat chow diet and tap water.
The rats were left for acclimatization for one week before the start of the study. 
3-Assessment of cardiac parameters:
Arterial blood pressure and heart rate were measured in rats using BIOPAC system weekly.
4-Histopathological assessment:
Rats were sacrificed under general anesthesia,Right kidney, heart, aorta, left common carotid artery and the normal arteries were collected, fixed in 10% neutral buffered formalin and embedded in paraffin. Each paraffin block was cut into 5 μm sections and stained with
Hematoxylin and Eosin (H&E). -Heart and blood vessels histopathology:
Interstitial edema, focal degeneration and congestion of cardiac myocytes were inspected by blind pathologist for histopathological changes.
The luminal, neointimal, and adventitial areas were also assessed.
4-Quantitative assessment of collagen type 1 and AT1R by ELISA
Freshly isolated blood vessels, heart and kidney were homogenized in 1 mL sterile phosphate buffered saline (PBS; Sigma-Aldrich Ltd, cat. No. P7059) pH 7.4. (15) .Resultant supernatants of the blood vessels, heart and kidneys were used for quantitative assessment of collagen type 1 and AT1R in rats using ELISA kits. (16) .
Statistical analysis:
One-way analysis of variance test was used to test the differences between the study groups followed byBonferroni test as a post-hoc.P < 0.05 was considered significant. 
Results

3-Spectrophotometric assay of oxidative stress markers in serum:
MDA levels showed significant increase in methionine group while SOD and reduced glutathione means showed significant increase in valsartan treated group (shown in table 3). 
4-Spectrophotometric
5-Quantitative assessment of AT1R in kidney,
heart and blood vessel AT1R in kidney and blood vessels showed a significant decrease after 12 weeks of methionine induction. Significant high levels of AT1R in Valsartan group when compared to methionine group. (shown in fig.2 ).
6-Histopathology
Kidney tubular, glomerular and congestion score showed significant difference among the three groups.GIII (treated with valsartan) has significant amelioration and preservation of tubular and glomerular architecture when compared to GII (methionine group). Congestion score showed significant decrease inGIII when compared to GII. (Table 4- 
Fig. (3):(A)Section from kidney tissue of GI showing normal kidney tissue; preserved architecture, No tubular changes (2) , No mesangial expansion and no sclerosing glomerulus (1) and no congestion (H&E X400). (B) Section from kidney tissue of GII showing large number of dilated tubules with widening of the
(4):(A): Section from heart tissue of GI showing normal heart tissue; preserved architecture, No interstitial edema, no focal degeneration of myocytes and no congestion. (B): Section from heart tissue of GII showing marked interstitial edema (1), moderate focal degeneration of myocytes (2) and mild congestion (3). (C): Section from heart tissue of GI showing normal heart tissue; preserved architecture, No interstitial edema, no focal degeneration of myocytes and no congestion.
(B): Section from blood vessels tissue of GII showing marked vacuolar degeneration of medial layer (1), moderate focal endothelial injury (2) and moderate increase in wall thickness (3). (C): Section from blood vessels tissue of GIII showing normal tissue; preserved architecture, no vacuolar degeneration of medial layer, No focal endothelial injury and average wall thickness.
Discussion
In this study, serum homocysteine level was We also found that heart rate decreasedin methionine-valsartan treated group (GIII) more than in methionine-induction group (GII). This result is concordant with other studies reporting that elevated plasma homocysteine level was associated with an increase in heart rate due to increased arterial stiffness which leads to hypertension and increased heart rate(23).
Elevation of serum SOD level in methionine- 
